中西医联合治疗儿童单症状性夜遗尿的疗效观察

注册号:

Registration number:

ITMCTR2025000428

最近更新日期:

Date of Last Refreshed on:

2025-02-27

注册时间:

Date of Registration:

2025-02-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

中西医联合治疗儿童单症状性夜遗尿的疗效观察

Public title:

Observation on the therapeutic effect of integrated traditional Chinese and Western medicine in the treatment of monosymptomatic nocturnal enuresis in children

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中西医联合治疗儿童单症状性夜遗尿的疗效观察

Scientific title:

Observation on the therapeutic effect of integrated traditional Chinese and Western medicine in the treatment of monosymptomatic nocturnal enuresis in children

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

贺金娥

研究负责人:

贺金娥

Applicant:

He Jine

Study leader:

He Jine

申请注册联系人电话:

Applicant telephone:

13700217809

研究负责人电话:

Study leader's telephone:

13700217809

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

113344730@qq.com

研究负责人电子邮件:

Study leader's E-mail:

113344730@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

陕西省延安市宝塔区北大街43号

研究负责人通讯地址:

陕西省延安市宝塔区北大街43号

Applicant address:

No. 43 Beidajie Street Baota District Yan'an City Shaanxi Province

Study leader's address:

No. 43 Beidajie Street Baota District Yan'an City Shaanxi Province

申请注册联系人邮政编码:

Applicant postcode:

716000

研究负责人邮政编码:

Study leader's postcode:

716000

申请人所在单位:

延安大学附属医院

Applicant's institution:

The Affiliated Hospital of Yan'an University

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

YAS-H01-202407003

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

延安大学附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of The Affiliated Hospital of Yan'an University

伦理委员会批准日期:

Date of approved by ethic committee:

2024/7/19 0:00:00

伦理委员会联系人:

张弓

Contact Name of the ethic committee:

Zhang Gong

伦理委员会联系地址:

陕西省延安市宝塔区北大街43号

Contact Address of the ethic committee:

No. 43 Beidajie Street Baota District Yan'an City Shaanxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

15209110112

伦理委员会联系人邮箱:

Contact email of the ethic committee:

113344730@qq.com

研究实施负责(组长)单位:

延安大学附属医院

Primary sponsor:

The Affiliated Hospital of Yan'an University

研究实施负责(组长)单位地址:

陕西省延安市宝塔区北大街43号

Primary sponsor's address:

No. 43 Beidajie Street Baota District Yan'an City Shaanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西省

市(区县):

Country:

China

Province:

Shaanxi Province

City:

单位(医院):

延安大学附属医院

具体地址:

陕西省延安市宝塔区北大街43号

Institution
hospital:

The Affiliated Hospital of Yan'an University

Address:

No. 43 Beidajie Street Baota District Yan'an City Shaanxi Province

经费或物资来源:

政府资金(延安市科学技术局合作项目)

Source(s) of funding:

government funds

研究疾病:

儿童单症状性夜遗尿

研究疾病代码:

Target disease:

Monosymptomatic Nocturnal Enuresis in Children

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

队列研究

Cohort study

研究所处阶段:

Study phase:

回顾性研究

Retrospective study

研究目的:

通过收集的资料进行统计学分析,通过研究中西医治疗及单纯西医治疗儿童原发性单症状夜遗尿症疗效研究,探索中西医联合治疗的疗效,进一步指导遗尿症患儿临床治疗。

Objectives of Study:

Through statistical analysis of collected data and a study on the efficacy of combined traditional Chinese and Western medicine treatment versus Western medicine-only treatment for primary monosymptomatic nocturnal enuresis in children we aim to explore the therapeutic effects of the combined treatment approach and further guide clinical treatment for children with enuresis.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄≥5岁~14岁; (2)平均每周至少2次夜间不自主排尿,持续3个月以上。

Inclusion criteria

(1)Age ≥5 ~14 years old; (2) lnvoluntary nighttime urination at least twice a week on average for more than 3 months.

排除标准:

(1)除外伴神经系统疾病、泌尿系统畸形、泌尿系统感染、糖尿病、尿崩症等继发疾病; (2)除外伴随白天漏尿、滴尿等伴随症状者。 入组病例均签署知情同意书。

Exclusion criteria:

Excluding those with: (1) Secondary diseases such as neurological disorders urinary tract malformations urinary tract infections diabetes and diabetes insipidus; (2) Accompanying symptoms such as daytime incontinence or dribbling urine. All enrolled patients have signed informed consent forms.

研究实施时间:

Study execute time:

From 2025-02-01

To      2026-08-01

征募观察对象时间:

Recruiting time:

From 2025-03-25

To      2025-09-25

干预措施:

Interventions:

组别:

单用西药组

样本量:

56

Group:

The group using Western medicine alone

Sample size:

干预措施:

回顾性收集单用西药的病例

干预措施代码:

Intervention:

Retrospectively collect cases of patients who used Western medicine alone.

Intervention code:

组别:

中西医联合用药组

样本量:

56

Group:

Combined Chinese and Western Medicine Medication Group

Sample size:

干预措施:

回顾性收集中西医联合用药的病例

干预措施代码:

Intervention:

Retrospectively collect cases of combined use of traditional Chinese and Western medicine.

Intervention code:

样本总量 Total sample size : 112

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

陕西省

市(区县):

Country:

China

Province:

Shaanxi Province

City:

单位(医院):

延安大学附属医院

单位级别:

三甲

Institution/hospital:

The Affiliated Hospital of Yan'an University

Level of the institution:

trimethylate

测量指标:

Outcomes:

指标中文名:

遗尿频率

指标类型:

次要指标

Outcome:

enuresis frequency

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

儿童睡眠习惯问卷在治疗前后评分的差值

指标类型:

次要指标

Outcome:

The difference in scores of the Children's Sleep Habits Questionnaire before and after treatment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

临床疗效

指标类型:

主要指标

Outcome:

clinical efficacy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

残余尿量

指标类型:

次要指标

Outcome:

residual urine volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

尿液

组织:

Sample Name:

urine

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 5
Min age years
最大 14
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

根据医院实际治疗方案,将患者分为中西医联合用药在组和单用西药组

Randomization Procedure (please state who generates the random number sequence and by what method):

Classified according to different treatment regimens

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

国际传统医学临床试验注册平台,http://itmctr.ccebtcm.org.cn/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

International Traditional Medicine Clinical Trial Registry Platform http://itmctr.ccebtcm.org.cn/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用CRF表收集数据,由3名研究员完成,并由1名研究者进行核查,最终数据由2名研究者将上述数据库录入并提交至国际传统医学临床试验注册平台。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The CRF form was used to collect data completed by three researchers and validated by one researcher. The final data were entered by two researchers and submitted to International Traditional Medicine Clinical Trial Registry Platform.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统